SCHEDULE: Cultivate(MD) Group Discloses 6.7% Stake in Shoulder Innovations

A group led by cultivate(MD) Holdings, LLC has reported a 6.7% beneficial ownership stake in Shoulder Innovations, Inc., totaling 1,363,394 shares.

Summary

• Reporting persons, cultivate(MD) Holdings, LLC and its directors/managing director (David Lawrence Blue, Matthew Fraser Ahearn, Robert Joseph Ball, and R. Sean Churchill), collectively beneficially own 1,363,394 shares of Shoulder Innovations, Inc. Common Stock.
• This represents 6.7% of the company's outstanding Common Stock.
• The shares are held across four entities: Cultivate MD Capital Fund I, LLC (185,623 shares), Cultivate MD Capital Fund II, LP (309,948 shares), Genesis Investment Holdings (592,585 shares), and cultivate(MD) Capital Accelerator Fund, L.P. (275,238 shares).
• cultivate(MD) Holdings, LLC acts as the general partner or manager for these funds, holding sole voting and dispositive power over the shares.
• The individual reporting persons share voting and dispositive power through their roles at cultivate(MD) Holdings, LLC but disclaim beneficial ownership beyond their pecuniary interest.

Sentiment

Score: 6

Explanation: The filing indicates a significant beneficial ownership stake by a group including an investment entity and its directors/managing director, suggesting a notable level of commitment and alignment of interests. While not directly financial performance, a substantial insider/institutional stake can be viewed positively by the market.

Positives

• A significant institutional and insider ownership stake (6.7%) by a group of investors and management personnel indicates alignment of interests with the company's performance.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• cultivate(MD) Holdings, LLC is the general partner or manager of Cultivate MD Capital Fund I, LLC, Cultivate MD Capital Fund II, LP, Genesis Investment Holdings, and cultivate(MD) Capital Accelerator Fund, L.P., which hold the reported shares.
• David Lawrence Blue, Matthew Fraser Ahearn, Robert Joseph Ball, and R. Sean Churchill are directors or a managing director of cultivate(MD) Holdings, LLC, establishing a related party relationship with the investment entity and the funds holding the shares.

Stakeholder Impact

• Shareholders: The disclosure of a significant 6.7% stake by a group including an investment firm and its key personnel may signal confidence in the company's prospects, potentially influencing investor sentiment.
• Company Management: The substantial ownership by cultivate(MD) Holdings, LLC and its leadership could imply a more engaged and influential shareholder base, potentially impacting strategic decisions and corporate governance.

Key Dates

Keywords

SHOULDER INNOVATIONS INC, cultivate(MD) Holdings, beneficial ownership, Schedule 13G, common stock, institutional investor, insider ownership, medical devices, healthcare investment